442-Q CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation

442-Q CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation

Bibliographic Details
Main Authors:	Torsten Tonn, Winfried Wels, Hans Klingemann, Jiri Eitler, Natalie Wotschel, Laurent Boissel, Paola Ortiz Montero, Wiebke Rackwitz, Venugopal Gudipati, Johannes Huppa
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation
by: Torsten Tonn, et al.
Published: (2024-02-01)

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
by: Torsten Tonn, et al.
Published: (2021-01-01)

Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer
by: Nivedha Murali Shankar, et al.
Published: (2023-10-01)

NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis
by: Kotaro Saga, et al.
Published: (2019-10-01)

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
by: Congcong Zhang, et al.
Published: (2017-05-01)

Natural killer cells for immunotherapy – Advantages of cell lines over blood NK cells
by: Hans eKlingemann, et al.
Published: (2016-03-01)

Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1
by: Le Tong, et al.
Published: (2023-07-01)

Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D
by: Mohammad Diab, et al.
Published: (2020-07-01)

Genetically modified natural killer cells specifically recognizing the tumor-associated antigens ErbB2/HER2 and EpCAM
by: Uherek B, et al.
Published: (2004-07-01)

Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK Cells
by: Einat Seidel, et al.
Published: (2015-02-01)

PROMOTER CHOICE: THE IDEAL PROMOTER TO DRIVE CHIMERIC ANTIGEN RECEPTOR (CAR) EXPRESSION IN NK CELLS
by: RN Silvestre, et al.
Published: (2021-10-01)

C/EBPβ-dependent autophagy inhibition hinders NK cell function in cancer
by: Federica Portale, et al.
Published: (2024-11-01)

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
by: Renata Nacasaki Silvestre, et al.
Published: (2023-09-01)

Acute Myeloid Leukemia Epigenetic Immune Escape From Nature Killer Cells by ICAM-1
by: Yang Xiao, et al.
Published: (2021-10-01)

442-J Anti-AXL CAR-NK cell immunotherapy to target BRAF inhibitor drug-resistant and metastatic melanoma
by: Yanlin Yu
Published: (2023-11-01)

Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20
by: Yoav Charpak-Amikam, et al.
Published: (2017-08-01)

EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.
by: Pranav Oberoi, et al.
Published: (2013-01-01)

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma
by: Catrin Heim, et al.
Published: (2023-08-01)

ENGINEERED CD19-CAR NK CELLS AS AN OFF-THE-SHELF ALTERNATIVE TO B CELL LEUKEMIA AND LYMPHOMA TREATMENT
by: R.N. Silvestre, et al.
Published: (2020-11-01)

Editorial: Translating NK cell scientific research to clinical product manufacturing
by: Evelyn Ullrich, et al.
Published: (2023-08-01)

442-I Enhancing TCR-T responses and overcoming the tumor microenvironment by combination with a TGFβ-specific CAR
by: Ximin Chen, et al.
Published: (2023-11-01)

LFA-1/ ICAM-1 promotes NK cell cytotoxicity associated with the pathogenesis of ocular toxoplasmosis in murine model.
by: Nannan Gao, et al.
Published: (2022-10-01)

Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
by: Catrin Heim, et al.
Published: (2024-06-01)

EEE 442 - Rangkaian Komputer
by: PPKEE, Pusat Pengajian Kejuruteraan Elektrik & Elektronik
Published: (1994)

Overcoming hypoxia-induced functional suppression of NK cells
by: Jeffrey Schlom, et al.
Published: (2020-05-01)

Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK Cells with Enhanced Antitumor Activity
by: Pranav Oberoi, et al.
Published: (2020-03-01)

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma
by: Michael W. Moles, et al.
Published: (2024-06-01)

JEE 442 - Rangkaian Perhubungan Data
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)

EBB442 - Quality Control And Management
by: PPKBSM, Pusat Pengajian Kejuruteraan Bahan dan Sumber Mineral

Overcoming tumor resistance mechanisms in CAR-NK cell therapy
by: Antonio Valeri, et al.
Published: (2022-08-01)

Overcoming Antigen Escape and T-Cell Exhaustion in CAR-T Therapy for Leukemia
by: Elżbieta Bartoszewska, et al.
Published: (2024-09-01)

Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape
by: Gang Zhou, et al.
Published: (2012-01-01)

Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
by: Arsen Osipov, et al.
Published: (2019-08-01)

THE EXPRESSION OF THE ADHESION MOLECULES PECAM, ICAM-1, ICAM-2, ICAM-3, E-SELECTIN AND P-SELECTIN IN BREAST-CANCER ENDOTHELIUM
by: Fox, S, et al.
Published: (1994)

ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo
by: Deborah L. W. Chong, et al.
Published: (2021-08-01)

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape
by: Valentina Folgiero, et al.
Published: (2021-03-01)

ID3 mediates BMP2-induced downregulation of ICAM1 expression in human endometiral stromal cells and decidual cells
by: Jin Luo, et al.
Published: (2023-02-01)

Getting CD19 Into Shape: Expression of Natively Folded “Difficult-to- Express” CD19 for Staining and Stimulation of CAR-T Cells
by: Elisabeth Lobner, et al.
Published: (2020-02-01)

Co-immunostaining of ICAM-1, ICAM-2, and CD31 in Mouse Kidney Glomeruli
by: Sun-sang Sung
Published: (2020-07-01)

EEE 442 - RANGKAIAN KOMPUTER NOV 05
by: PPKEE, Pusat Pengajian Kejuruteraan Elektrik & Elektronik
Published: (2005)